Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 12

1.

CXCR6 regulates localization of tissue-resident memory CD8 T cells to the airways.

Wein AN, McMaster SR, Takamura S, Dunbar PR, Cartwright EK, Hayward SL, McManus DT, Shimaoka T, Ueha S, Tsukui T, Masumoto T, Kurachi M, Matsushima K, Kohlmeier JE.

J Exp Med. 2019 Sep 26. pii: jem.20181308. doi: 10.1084/jem.20181308. [Epub ahead of print]

PMID:
31558615
2.

IL-36γ Protects against Severe Influenza Infection by Promoting Lung Alveolar Macrophage Survival and Limiting Viral Replication.

Wein AN, Dunbar PR, McMaster SR, Li ZT, Denning TL, Kohlmeier JE.

J Immunol. 2018 Jul 15;201(2):573-582. doi: 10.4049/jimmunol.1701796. Epub 2018 May 30.

3.

B cell activation and plasma cell differentiation are inhibited by de novo DNA methylation.

Barwick BG, Scharer CD, Martinez RJ, Price MJ, Wein AN, Haines RR, Bally APR, Kohlmeier JE, Boss JM.

Nat Commun. 2018 May 15;9(1):1900. doi: 10.1038/s41467-018-04234-4.

4.

Pulmonary antigen encounter regulates the establishment of tissue-resident CD8 memory T cells in the lung airways and parenchyma.

McMaster SR, Wein AN, Dunbar PR, Hayward SL, Cartwright EK, Denning TL, Kohlmeier JE.

Mucosal Immunol. 2018 Jul;11(4):1071-1078. doi: 10.1038/s41385-018-0003-x. Epub 2018 Feb 16.

5.

An anthrax toxin variant with an improved activity in tumor targeting.

Wein AN, Peters DE, Valivullah Z, Hoover BJ, Tatineni A, Ma Q, Fattah R, Bugge TH, Leppla SH, Liu S.

Sci Rep. 2015 Nov 20;5:16267. doi: 10.1038/srep16267.

6.

Key tissue targets responsible for anthrax-toxin-induced lethality.

Liu S, Zhang Y, Moayeri M, Liu J, Crown D, Fattah RJ, Wein AN, Yu ZX, Finkel T, Leppla SH.

Nature. 2013 Sep 5;501(7465):63-8. doi: 10.1038/nature12510. Epub 2013 Aug 28.

7.

Engineering anthrax toxin variants that exclusively form octamers and their application to targeting tumors.

Phillips DD, Fattah RJ, Crown D, Zhang Y, Liu S, Moayeri M, Fischer ER, Hansen BT, Ghirlando R, Nestorovich EM, Wein AN, Simons L, Leppla SH, Leysath CE.

J Biol Chem. 2013 Mar 29;288(13):9058-65. doi: 10.1074/jbc.M113.452110. Epub 2013 Feb 7.

8.

Interactions of high-affinity cationic blockers with the translocation pores of B. anthracis, C. botulinum, and C. perfringens binary toxins.

Bezrukov SM, Liu X, Karginov VA, Wein AN, Leppla SH, Popoff MR, Barth H, Nestorovich EM.

Biophys J. 2012 Sep 19;103(6):1208-17. doi: 10.1016/j.bpj.2012.07.050.

9.

Small molecule inhibitors of Bacillus anthracis protective antigen proteolytic activation and oligomerization.

Wein AN, Williams BN, Liu S, Ermolinsky B, Provenzano D, Abagyan R, Orry A, Leppla SH, Peredelchuk M.

J Med Chem. 2012 Sep 27;55(18):7998-8006. Epub 2012 Sep 18.

10.

Diphthamide modification on eukaryotic elongation factor 2 is needed to assure fidelity of mRNA translation and mouse development.

Liu S, Bachran C, Gupta P, Miller-Randolph S, Wang H, Crown D, Zhang Y, Wein AN, Singh R, Fattah R, Leppla SH.

Proc Natl Acad Sci U S A. 2012 Aug 21;109(34):13817-22. doi: 10.1073/pnas.1206933109. Epub 2012 Aug 6.

11.

Tumor therapy with a urokinase plasminogen activator-activated anthrax lethal toxin alone and in combination with paclitaxel.

Wein AN, Liu S, Zhang Y, McKenzie AT, Leppla SH.

Invest New Drugs. 2013 Feb;31(1):206-12. doi: 10.1007/s10637-012-9847-1. Epub 2012 Jul 28.

12.

Tumor cytotoxicity of 5,6-dimethyl-1,10-phenanthroline and its corresponding gold(III) complex.

Wein AN, Stockhausen AT, Hardcastle KI, Saadein MR, Peng SB, Wang D, Shin DM, Chen ZG, Eichler JF.

J Inorg Biochem. 2011 May;105(5):663-8. doi: 10.1016/j.jinorgbio.2011.01.006. Epub 2011 Jan 22.

PMID:
21450269

Supplemental Content

Support Center